Skinfold thickness as an indicator of neonatal hypoglycaemia in infants with birthweights over 2500g

Insights

Full-term infants over 2500g can experience neonatal hypoglycemia. Low subcutaneous fat, indicated by skinfold thickness, correlates with lower plasma glucose, but isn't a reliable screening tool.

Area of Science:

  • Neonatal Medicine
  • Pediatric Endocrinology

Background:

  • Neonatal hypoglycemia affects some full-term infants with birthweights over 2500g.
  • These infants often exhibit signs of poor nourishment, specifically reduced subcutaneous fat.
  • Identifying predictive markers for hypoglycemia in this population is crucial.

Purpose of the Study:

  • To investigate the relationship between subcutaneous fat stores and plasma glucose levels in term neonates.
  • To assess the potential of skinfold thickness as an objective indicator for predicting neonatal hypoglycemia.

Main Methods:

  • A study of 100 normal, term infants with birthweights exceeding 2500g.
  • Measurement of standard deviation scores for skinfold thickness relative to birthweight as a proxy for nutritional status.
  • Analysis of plasma glucose levels at four hours of age in relation to skinfold thickness scores.

Main Results:

  • Infants with lower skinfold standard deviation scores demonstrated significantly lower plasma glucose levels at four hours.
  • A statistically significant, though weak, correlation was found between plasma glucose and skinfold standard deviation scores.
  • The correlation was insufficient for use as a reliable screening method for neonatal hypoglycemia.

Conclusions:

  • Subcutaneous fat stores, assessed by skinfold thickness, are linked to neonatal glucose levels in term infants over 2500g.
  • While indicative, skinfold thickness alone is not a sufficiently accurate predictor for screening neonatal hypoglycemia in this group.
  • Further research is needed to identify objective measurements for predicting neonatal hypoglycemia in term neonates with higher birthweights.